1,582 results on '"Dagna, Lorenzo"'
Search Results
2. Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
3. Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial
4. Clinical Aspects of Rheumatoid Arthritis
5. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
6. High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation
7. Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies
8. Heart failure in systemic immune-mediated diseases
9. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
10. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis
11. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
12. A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis
13. A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis
14. Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands
15. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
16. Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study
17. Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center
18. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
19. Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
20. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study
21. Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction
22. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
23. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
24. IgE response to Aed al 13 and Aed al 14 recombinant allergens from Aedes albopictus saliva in humans
25. Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort
26. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
27. Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report
28. Association of IgG4-related disease and systemic rheumatic disorders
29. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
30. Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial
31. The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry
32. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
33. Giant cell arteritis: Update on clinical manifestations, diagnosis, and management
34. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients
35. Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study
36. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
37. Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases
38. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
39. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
40. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis
41. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature
42. Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors
43. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
44. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology
45. Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
46. One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation
47. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
48. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
49. Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients
50. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.